The week of Jan. 20, 2025, made history in a way few Americans realize. For the first time in 128 years, the Morbidity and ...

Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...

and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Patient organisations have been celebrating the FDA approval yesterday of Amylyx' amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that ...

After hours: February 14 at 7:59:47 PM EST Loading Chart for MRK ...

After hours: February 14 at 7:59:47 p.m. EST ...

The week of Jan. 20, 2025, made history in a way few Americans realize. For the first time in 128 years, the Morbidity and ...